BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

743 related articles for article (PubMed ID: 9989963)

  • 21. CORonary Diet Intervention with Olive oil and cardiovascular PREVention study (the CORDIOPREV study): Rationale, methods, and baseline characteristics: A clinical trial comparing the efficacy of a Mediterranean diet rich in olive oil versus a low-fat diet on cardiovascular disease in coronary patients.
    Delgado-Lista J; Perez-Martinez P; Garcia-Rios A; Alcala-Diaz JF; Perez-Caballero AI; Gomez-Delgado F; Fuentes F; Quintana-Navarro G; Lopez-Segura F; Ortiz-Morales AM; Delgado-Casado N; Yubero-Serrano EM; Camargo A; Marin C; Rodriguez-Cantalejo F; Gomez-Luna P; Ordovas JM; Lopez-Miranda J; Perez-Jimenez F
    Am Heart J; 2016 Jul; 177():42-50. PubMed ID: 27297848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial.
    Holman RR; Coleman RL; Chan JCN; Chiasson JL; Feng H; Ge J; Gerstein HC; Gray R; Huo Y; Lang Z; McMurray JJ; Rydén L; Schröder S; Sun Y; Theodorakis MJ; Tendera M; Tucker L; Tuomilehto J; Wei Y; Yang W; Wang D; Hu D; Pan C;
    Lancet Diabetes Endocrinol; 2017 Nov; 5(11):877-886. PubMed ID: 28917545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up.
    LIPID Study Group (Long-term Intervention with Pravastatin in Ischaemic Disease)
    Lancet; 2002 Apr; 359(9315):1379-87. PubMed ID: 11978335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mediterranean diet and coronary heart disease: are antioxidants critical?
    Trichopoulou A; Vasilopoulou E; Lagiou A
    Nutr Rev; 1999 Aug; 57(8):253-5. PubMed ID: 10518412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.
    BMJ; 1994 Jan; 308(6921):81-106. PubMed ID: 8298418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Mediterranean diet in secondary prevention of coronary heart disease.
    de Lorgeril M; Salen P
    Clin Invest Med; 2006 Jun; 29(3):154-8. PubMed ID: 17058434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease.
    de Lorgeril M; Renaud S; Mamelle N; Salen P; Martin JL; Monjaud I; Guidollet J; Touboul P; Delaye J
    Lancet; 1994 Jun; 343(8911):1454-9. PubMed ID: 7911176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial.
    Ikeda Y; Shimada K; Teramoto T; Uchiyama S; Yamazaki T; Oikawa S; Sugawara M; Ando K; Murata M; Yokoyama K; Ishizuka N
    JAMA; 2014 Dec; 312(23):2510-20. PubMed ID: 25401325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship between adherence to the Mediterranean diet and the severity and short-term prognosis of acute coronary syndromes (ACS): The Greek Study of ACS (The GREECS).
    Panagiotakos DB; Arapi S; Pitsavos C; Antonoulas A; Mantas Y; Zombolos S; Stefanadis C
    Nutrition; 2006; 22(7-8):722-30. PubMed ID: 16730948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. OASIS (Organisation to Assess Strategies for Ischaemic Syndromes) Registry Investigators.
    Yusuf S; Flather M; Pogue J; Hunt D; Varigos J; Piegas L; Avezum A; Anderson J; Keltai M; Budaj A; Fox K; Ceremuzynski L
    Lancet; 1998 Aug; 352(9127):507-14. PubMed ID: 9716054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum cholesterol as a prognostic factor after myocardial infarction: the Framingham Study.
    Wong ND; Wilson PW; Kannel WB
    Ann Intern Med; 1991 Nov; 115(9):687-93. PubMed ID: 1929036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usefulness of hospital admission risk stratification for predicting nonfatal acute myocardial infarction or death six months later in unstable angina pectoris. RESCATE Study Group. Resources Used in Acute Coronary Syndromes and Delays in Treatment.
    Serés L; Valle V; Marrugat J; Sanz G; Masiá R; Lupón J; Curós A; Sala J; Molina L; Pavesi M
    Am J Cardiol; 1999 Nov; 84(9):963-9. PubMed ID: 10569647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network.
    Giannuzzi P; Temporelli PL; Marchioli R; Maggioni AP; Balestroni G; Ceci V; Chieffo C; Gattone M; Griffo R; Schweiger C; Tavazzi L; Urbinati S; Valagussa F; Vanuzzo D;
    Arch Intern Med; 2008 Nov; 168(20):2194-204. PubMed ID: 19001195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: Results from the LIPID trial.
    Hunt D; Young P; Simes J; Hague W; Mann S; Owensby D; Lane G; Tonkin A
    Ann Intern Med; 2001 May; 134(10):931-40. PubMed ID: 11352694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The AUStralian MEDiterranean Diet Heart Trial (AUSMED Heart Trial): A randomized clinical trial in secondary prevention of coronary heart disease in a multiethnic Australian population: Study protocol.
    Itsiopoulos C; Kucianski T; Mayr HL; van Gaal WJ; Martinez-Gonzalez MA; Vally H; Kingsley M; Kouris-Blazos A; Radcliffe J; Segal L; Brazionis L; Salim A; Tierney AC; O'Dea K; Wilson A; Thomas CJ
    Am Heart J; 2018 Sep; 203():4-11. PubMed ID: 29966802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of antecedent hypertension and follow-up blood pressure on outcomes after high-risk myocardial infarction.
    Thune JJ; Signorovitch J; Kober L; Velazquez EJ; McMurray JJ; Califf RM; Maggioni AP; Rouleau JL; Howlett J; Zelenkofske S; Pfeffer MA; Solomon SD
    Hypertension; 2008 Jan; 51(1):48-54. PubMed ID: 18025296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mediterranean diet for heart disease.
    Douglas M
    J Fam Pract; 1999 May; 48(5):333-4. PubMed ID: 10334604
    [No Abstract]   [Full Text] [Related]  

  • 38. The 'diet heart' hypothesis in secondary prevention of coronary heart disease.
    de Lorgeril M; Salen P; Monjaud I; Delaye J
    Eur Heart J; 1997 Jan; 18(1):13-8. PubMed ID: 9049509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular effects of tamoxifen in women with and without heart disease: breast cancer prevention trial. National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial Investigators.
    Reis SE; Costantino JP; Wickerham DL; Tan-Chiu E; Wang J; Kavanah M
    J Natl Cancer Inst; 2001 Jan; 93(1):16-21. PubMed ID: 11136837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study.
    Hague W; Forder P; Simes J; Hunt D; Tonkin A;
    Am Heart J; 2003 Apr; 145(4):643-51. PubMed ID: 12679760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.